These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25604203)

  • 1. Renal and metabolic effects of valsartan.
    Ecder T
    Anadolu Kardiyol Derg; 2014 Dec; 14 Suppl 2():S14-9. PubMed ID: 25604203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and valsartan.
    Kızılırmak P; Üresin AY
    Anadolu Kardiyol Derg; 2014 Dec; 14 Suppl 2():S20-4. PubMed ID: 25604204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.
    Böger RH; Schwedhelm E; Maas R; Quispe-Bravo S; Skamira C
    Vasc Med; 2005 Jul; 10 Suppl 1():S97-102. PubMed ID: 16444875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of valsartan on the progression of chronic renal insufficiency in patients with nondiabetic renal diseases.
    Ishimitsu T; Kameda T; Akashiba A; Takahashi T; Ando N; Ohta S; Yoshii M; Inada H; Tsukada K; Minami J; Ono H; Matsuoka H
    Hypertens Res; 2005 Nov; 28(11):865-70. PubMed ID: 16555574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the renoprotective effects of benidipine and valsartan in primary hypertensive patients with proteinuria.
    Peng T; Hu Z; Xia Q; Jiang B; Li X; Yang X
    Arzneimittelforschung; 2009; 59(12):647-50. PubMed ID: 20108651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK; Leung CB; Chow KM; Cheng YL; Fung SK; Mak SK; Tang AW; Wong TY; Yung CY; Yung JC; Yu AW; Szeto CC;
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus.
    Yoneda T; Takeda Y; Usukura M; Oda N; Takata H; Yamamoto Y; Karashima S; Yamagishi M
    Am J Hypertens; 2007 Dec; 20(12):1329-33. PubMed ID: 18047925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.
    Sironi L; Gelosa P; Guerrini U; Banfi C; Crippa V; Brioschi M; Gianazza E; Nobili E; Gianella A; de Gasparo M; Tremoli E
    J Pharmacol Exp Ther; 2004 Dec; 311(3):989-95. PubMed ID: 15302895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
    Lee YJ; Jang HR; Kim SG; Chae DW; Do JY; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
    Nephrology (Carlton); 2011 Jul; 16(5):502-10. PubMed ID: 21303424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model.
    Tominaga N; Robert A; Izuhara Y; Ohtomo S; Dan T; Chihara K; Kurokawa K; Van Ypersele de Strihou C; Miyata T
    Nephrology (Carlton); 2009 Sep; 14(6):581-7. PubMed ID: 19712258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials.
    Mistry NB; Westheim AS; Kjeldsen SE
    Expert Opin Pharmacother; 2006 Apr; 7(5):575-81. PubMed ID: 16553573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren/valsartan (Valturna) for hypertension.
    Med Lett Drugs Ther; 2009 Nov; 51(1326):94-5. PubMed ID: 20224524
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus.
    Yang ZH; Peng XD
    Chin Med J (Engl); 2010 Dec; 123(24):3640-3. PubMed ID: 22166644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of valsartan on lipid profile in normotensive type 2 diabetic patients.
    Velija-Asimi Z; Heljić B
    Med Arh; 2005; 59(5):311-2. PubMed ID: 16134756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S; Yagi S; Yamamoto H; Yamaguchi M; Izumida T; Noguchi Y; Inaba M; Inukai K
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system blockade in the treatment of heart failure and the role of valsartan in this treatment.
    Kılıçkıran Avcı B; İkitimur B; Karadağ B; Öngen Z
    Anadolu Kardiyol Derg; 2014 Dec; 14 Suppl 2():S1-8. PubMed ID: 25604202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.